Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03948100 · ClinicalTrials.gov registry record · NA

Dyadic Yoga Intervention in Improving Physical Performance and Quality of Life in Patients With Stage I-IV Non-small Cell Lung or Esophageal Cancer Undergoing Radiotherapy and Their Caregivers

A NA study of Lung Non-Small Cell Carcinoma and Stage II Lung Cancer AJCC v8, sponsored by M.D. Anderson Cancer Center.

Recruiting
Registry status
NA
Development phase
400
Enrollment target
1
Study location

NCT03948100: Recruiting NA study of Lung Non-Small Cell Carcinoma and Stage II Lung Cancer AJCC v8, sponsored by M.D. Anderson Cancer Center.

NCT03948100 is a NA study of Lung Non-Small Cell Carcinoma and Stage II Lung Cancer AJCC v8 that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 400 participants, above the 152-participant average among 47 other Lung Non-Small Cell Carcinoma trials with a reported enrollment target (163% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03948100, a NA study of Lung Non-Small Cell Carcinoma and Stage II Lung Cancer AJCC v8, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.

RECRUITING
Registry status
NA
Development phase
400 participants
Enrollment target
1
Study location

Study Summary

This trial studies how well dyadic yoga intervention works in improving physical performance and quality of life in patients with stage I-IV non-small cell lung or esophageal cancer undergoing radiotherapy and their caregivers. Dyadic yoga intervention may help to improve physical function, fatigue, sleep difficulties, depressive symptoms, and overall quality of life for patients with non-small cell lung cancer and/or their caregivers.

Primary Outcome

Descriptive statistics for study variables and potential covariates will be computed and distribution characteristics of the variables will be examined. The difference between dyadic yoga (DY) and dyadic edication (DE) at 3 month follow-up (3MFU) will be tested at a two-sided .05 significance level.

Interventions

  • OTHER Quality-of-Life Assessment
  • OTHER Questionnaire Administration
  • OTHER Educational Intervention
  • PROCEDURE Yoga

Study Locations (1)

Texas

  • M D Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2018-12-20
Est. Completion 2027-04-30
Phase NA
M.D. Anderson Cancer Center

2,692 total trials

What NCT03948100 shows while recruiting

NCT03948100 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, above the 152-participant average among 47 other Lung Non-Small Cell Carcinoma trials with a reported enrollment target (163% higher).

The record links to 10 conditions, with Lung Non-Small Cell Carcinoma appearing as the primary indexed condition, and to 4 interventions - of which Quality-of-Life Assessment is the first listed.

NCT03948100 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT03948100 about?

NCT03948100 is a clinical study titled "Dyadic Yoga Intervention in Improving Physical Performance and Quality of Life in Patients With Stage I-IV Non-small Cell Lung or Esophageal Cancer Undergoing Radiotherapy and Their Caregivers". This trial studies how well dyadic yoga intervention works in improving physical performance and quality of life in patients with stage I-IV non-small cell lung or esophageal cancer undergoing radiotherapy and their caregivers. Dyadic yoga intervention may help to improve physical function, fatigue,...

What is the current status of trial NCT03948100?

This trial is currently recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2018-12-20. Estimated completion is 2027-04-30.

What conditions does trial NCT03948100 study?

This clinical trial studies the following conditions: Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8, Esophageal Carcinoma, Stage I Lung Cancer AJCC v8, Stage IIA Lung Cancer AJCC v8.

What interventions are being tested in trial NCT03948100?

The interventions under investigation include: Quality-of-Life Assessment (OTHER), Questionnaire Administration (OTHER), Educational Intervention (OTHER), Yoga (PROCEDURE).

Who is sponsoring clinical trial NCT03948100?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03948100 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lung Non-Small Cell Carcinoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03948100's enrollment target sits among peer trials

400 5th of 47 higher than 43 of 47 other Lung Non-Small Cell Carcinoma trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Lung Non-Small Cell Carcinoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01665326 · 400 participants

    Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease

  • NCT02108054 · 400 participants · NA

    Behavioral and Functional Task Development, Implementation, and Testing

  • NCT02216500 · 400 participants · NA

    Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy

  • NCT02250352 · 400 participants

    Core Biopsies for Establishing a Breast Tumor Tissue Repository

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03948100, the US trial registry maintained by the National Library of Medicine. NCT03948100 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.